TrialNature medicine2021

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Katie J Ewer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.